COHEN ABRAHAM E 4
4 · NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ · Filed Dec 14, 2004
Insider Transaction Report
Form 4
COHEN ABRAHAM E
Director
Transactions
- Sale
Common Stock
2004-12-10$4.17/sh−8,000$33,360→ 537,747 total - Sale
Common Stock
2004-12-10$4.21/sh−1,400$5,894→ 525,747 total - Exercise/Conversion
Common Stock
2004-12-10$2.88/sh+20,000$57,500→ 545,747 total - Sale
Common Stock
2004-12-10$4.16/sh−6,200$25,792→ 531,547 total - Exercise/Conversion
Stock Option (Right to Buy)
2004-12-10−20,000→ 0 totalExercise: $2.88From: 1999-01-01Exp: 2004-12-31→ Common Stock (20,000 underlying) - Sale
Common Stock
2004-12-10$4.25/sh−4,400$18,700→ 527,147 total
Footnotes (1)
- [F1]Non-qualified stock option grant for a total of 20,000 shares was made on 1/1/95 and became fully exercisable on 1/1/99 and expires on 12/31/04.